The Third Britton Chance International Symposium on Metabolic Imaging and Spectroscopy

July 17-20, 2024
Rubenstein Auditorium, Smilow Center for Translational Research

Registration is now closed. On-site registration is now closed. 

Dear colleagues and friends,

The Third Britton Chance International Symposium on Metabolic Imaging/Spectroscopy will be on July 17-20, 2024 at the University of Pennsylvania. The event will honor the 110th birthday of Britton Chance in a way that he would have loved: with a multi-disciplinary scientific program.

As you know, the scientific career of Britton Chance spanned eight decades and was recognized by the US National Medal of Science and memberships in the National Academy of Sciences of six countries. It is rare for a scientist to accomplish so much in so many disciplines (and the Olympics). Dr. Chance’s career was characterized by an extraordinary range of research insight and innovation, as well as a tenacious pursuit for clinical translation of new technologies. In parallel with his research, Dr. Chance helped build a research community by training and mentoring a remarkable stream of junior researchers spanning from high school students to faculty, and promoting global scientific cooperation and technology development. In this spirit, we invite you to attend and participate in the symposium.

Metabolism was a central theme of Dr. Chance’s research. In the 1930s, he invented miniature stop-flow instruments and used them to make seminal contributions to our understanding of enzymatic kinetics and to experimentally demonstrate enzyme-substrate complexes. In the 1950s, he invented the dual-beam spectrophotometer and used it in pioneering investigations of bioenergetics and the mitochondrial redox state in biological systems. In the 1960s he discovered electronic tunneling processes in biological systems. In the 1970s he identified hydrogen peroxide released by the respiratory chain in mitochondria. In the 1970-80s, he was a key player in the development of in vivo magnetic resonance spectroscopy, and in the 1990s he was a founding father of the field of biophotonics, especially for biomedical research and clinical practice. His students, collaborators, and colleagues have had a profound impact on a variety of fields.

This symposium aims to showcase cutting-edge research innovation and clinical translation in metabolic imaging and spectroscopy by methods based on optics, magnetic resonance, nuclear medicine, mass spectrometry, ultrasound, and more. To this end, it will bring together physicists, engineers, biologists, and clinicians for discussion and presentation of recent innovations and clinical progress.

We specifically encourage the participation of junior researchers (students, postdocs, trainees, and early-stage investigators) in the conference presentations and networking opportunities. We sincerely request senior investigators and supervisors forward this opportunity to the young researchers and support their participation. The organizers will provide a number of travel stipends and poster awards to selected junior researchers.

In addition, everyone is invited to contribute manuscripts to journal issues on metabolic imaging/spectroscopy in the Journal of Biomedical Optics and Academic Radiology.

We hope to see you in Philadelphia in July.

Best regards,

Lin Z. Li, PhD & Arjun G. Yodh, PhD
Chairs for the Organizing Committee